We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Omeros

News List

Omeros’ investigational new drug application for OMS906 cleared by FDA pharmaceutical-business-review
September 03, 2020
Omeros Corporation today announced that its Investigational New Drug Application (IND) to begin clinical trials with OMS906 has been cleared by the U.S. Food and Drug Administration (FDA).
Omeros reports positive results for Narsoplimab in treatment of Covid-19-associated ARDS pharmaceutical-business-review
August 13, 2020
Omeros Corporation reported the results of a compassionate-use study evaluating narsoplimab, Omeros’ investigational human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2) ...
Omeros, Lonza Enter Commercial Manufacturing Agreement contractpharma
August 01, 2019
Builds on existing clinical supply deal for narsoplimab.
Omeros Finalizes with FDA Clinical Plan for OMS721 Approval in IgA Nephropathy americanpharmaceuticalreview
January 21, 2019
Omeros has finalized its clinical plan for OMS721 submission and approval in immunoglobulin A nephropathy (IgAN) following a recent meeting with the U.S. Food and Drug Administration (FDA).....
Omeros defends drug data, vows to unmask short seller fiercebiotech
August 25, 2017
Omeros put out the statement to fend off attacks on two fronts.